Figure 4

(a–d) Myc overexpression was correlated with significantly higher levels of MDM2, IRF4, and MME/CD10 mRNA expression in germinal center B-cell-like (GCB) diffuse large B-cell lymphoma and significantly higher levels of FOXP1 and IRF4 mRNA expression in activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL). (e) The MYC-R+/Mychigh compared with MYC-R−/Mychigh group had significantly lower levels of MUM1 expression. (f–j) The MDM2, CD30, CD10, and FOXP1 levels in Mychigh GCB-DLBCL patients with MYC translocation were significantly different from those of Mychigh GCB-DLBCL patients without MYC translocation. (k and l) The Bcl-6 and pAKT levels of Mychigh ABC-DLBCL patients with MYC translocation were significantly lower compared with those of Mychigh ABC-DLBCL patients without MYC translocation. Mychigh, high Myc protein expression; Myclow, low Myc protein expression; MYC-R+, MYC rearrangement-positive; MYC-R−, MYC rearrangement-negative; MYC-RN/A, MYC rearrangement status not available.